CAR-T and CRISPR Australia

CAR-T Immunotherapy Technology

Chimeric Antigen Receptor enhanced T-cells (CAR T-cells)

  • A comprehensive platform of Next Gen Immunotherapy.
  • Cellular Bioengineering of the immune system: The new frontier of personalised medicine to defeat cancer.
  • Off the shelf treatments.

CAR T-Cell Therapy

  • This is a promising new way to get immune cells called T cells to fight cancer. for this technique, T cells are removed from the patient’s blood and genetically altered in the lab to have specific antigen receptors (called chimeric antigen receptors, or CARs) on their surface.
  • These receptors will attach to proteins on the surface of cancer calls. The T cells are then multiplied in the lab and infused back into the patient’s blood, where they can now seek out the cancer cells and launch a precise immune attack against them.
  • By modifying T cells to express chimeric antigen receptors (CARs) that recognize cancer-specific antigens, researchers can prime the cells to recognize and kills tumour cells that would otherwise escape immune detection. The process involves extracting a patient’s T cells, transfecting them with a gene for a CAR, then reinfusing the transfected cells into the patient.